Product Code: ETC6273467 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The opioid-induced constipation (OIC) drugs market in Bahrain is growing as awareness of opioid side effects, particularly constipation, increases. Opioid medications, while effective in managing pain, are often associated with gastrointestinal issues, with constipation being one of the most common side effects. This has led to an increasing demand for medications that specifically address OIC, including laxatives, stool softeners, and newer therapies designed to counteract these side effects without compromising pain relief. The market in Bahrain is being driven by the rising prescription rates for opioids and the increasing recognition of the need for specialized treatment options. Pharmaceutical companies are focusing on developing targeted therapies to manage OIC, ensuring better patient comfort and compliance. As the healthcare system in Bahrain evolves to address these issues, the OIC drug market is expected to continue growing.
The market for opioid-induced constipation (OIC) drugs in Bahrain is growing alongside the broader use of opioids in clinical settings. As more patients rely on opioids for chronic pain management, side effects like constipation have led to increased demand for targeted treatments. Peripherally acting mu-opioid receptor antagonists (PAMORAs) and other novel therapies are being introduced and adopted due to their ability to treat OIC without compromising analgesic efficacy. The expansion of palliative and cancer care services is also boosting the need for supportive therapies like OIC medications. Moreover, a rise in outpatient and home-based care has fueled the demand for convenient oral OIC drug formulations. Improved diagnosis and physician awareness continue to contribute to the growth of this therapeutic niche.
The market for opioid-induced constipation drugs in Bahrain faces challenges due to its niche nature and limited awareness among healthcare providers and patients. High treatment costs and reimbursement issues hinder widespread adoption. Import reliance and regulatory approval processes create supply uncertainties. Additionally, the market competes with over-the-counter laxatives and alternative therapies, limiting growth. Stigma associated with opioid use further reduces patient willingness to seek treatment. The small patient population within Bahrain constrains economies of scale, impacting market attractiveness. These factors collectively slow the growth of this specialized segment.
The Bahrain Opioid Induced Constipation (OIC) Drugs Market is gaining importance as a complementary treatment segment to opioid therapy. With the rising use of opioids for pain management, the incidence of OIC is a significant clinical challenge, increasing demand for effective laxatives and bowel management drugs. Investing in innovative, targeted OIC therapies with improved efficacy and safety profiles can capture market share. The growing geriatric population and cancer patient base contribute to expanding the patient pool. Collaborations with healthcare providers and inclusion in palliative care protocols will enhance drug adoption. Government initiatives to improve patient quality of life align with growth in this segment. This niche market presents a specialized yet crucial investment opportunity linked to broader opioid therapy trends.
Opioid-induced constipation (OIC) is recognized as a treatment-related side effect, and the government allows the import and sale of approved drugs to manage it. The NHRA reviews such drugs for safety and efficacy, especially those classified under gastrointestinal agents. While these medications are not covered under all public insurance schemes, subsidies may be provided on a case-by-case basis for chronic pain patients. The Ministry of Health encourages doctors to consider preventive and supportive care options when prescribing opioids, including OIC medications. Public and professional awareness programs are in place to ensure patients report and manage side effects early. Pharmacies require clear labeling and usage instructions on such products to avoid misuse. These policies aim to improve the quality of life for long-term opioid users.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahrain Opioid Induced Constipation Drugs Market Overview |
3.1 Bahrain Country Macro Economic Indicators |
3.2 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Bahrain Opioid Induced Constipation Drugs Market - Industry Life Cycle |
3.4 Bahrain Opioid Induced Constipation Drugs Market - Porter's Five Forces |
3.5 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Active Ingredients, 2021 & 2031F |
3.6 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.8 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Bahrain Opioid Induced Constipation Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Bahrain Opioid Induced Constipation Drugs Market Trends |
6 Bahrain Opioid Induced Constipation Drugs Market, By Types |
6.1 Bahrain Opioid Induced Constipation Drugs Market, By Active Ingredients |
6.1.1 Overview and Analysis |
6.1.2 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Active Ingredients, 2021- 2031F |
6.1.3 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Naloxegol, 2021- 2031F |
6.1.4 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Lubiprostone, 2021- 2031F |
6.1.5 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Methylnaltrexone Bromide, 2021- 2031F |
6.1.6 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Docusate Sodium, 2021- 2031F |
6.1.7 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Bahrain Opioid Induced Constipation Drugs Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Over The Counter Medicines, 2021- 2031F |
6.2.3 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Prescription, 2021- 2031F |
6.2.4 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Natural Remedies, 2021- 2031F |
6.3 Bahrain Opioid Induced Constipation Drugs Market, By Mode of Administration |
6.3.1 Overview and Analysis |
6.3.2 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Bahrain Opioid Induced Constipation Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Bahrain Opioid Induced Constipation Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Bahrain Opioid Induced Constipation Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Bahrain Opioid Induced Constipation Drugs Market Import-Export Trade Statistics |
7.1 Bahrain Opioid Induced Constipation Drugs Market Export to Major Countries |
7.2 Bahrain Opioid Induced Constipation Drugs Market Imports from Major Countries |
8 Bahrain Opioid Induced Constipation Drugs Market Key Performance Indicators |
9 Bahrain Opioid Induced Constipation Drugs Market - Opportunity Assessment |
9.1 Bahrain Opioid Induced Constipation Drugs Market Opportunity Assessment, By Active Ingredients, 2021 & 2031F |
9.2 Bahrain Opioid Induced Constipation Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Bahrain Opioid Induced Constipation Drugs Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.4 Bahrain Opioid Induced Constipation Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Bahrain Opioid Induced Constipation Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Bahrain Opioid Induced Constipation Drugs Market - Competitive Landscape |
10.1 Bahrain Opioid Induced Constipation Drugs Market Revenue Share, By Companies, 2024 |
10.2 Bahrain Opioid Induced Constipation Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |